Israeli Stocks: D. Medical, Teva Pharmaceutical Industries
Israel’s TA-25 Index retreated 1.4 percent, the most since March 13, to 1,296.03 at the 4:30 p.m. close in Tel Aviv. Investors traded about 1.34 billion shekels ($396 million) in shares and convertible securities.
The following stocks rose or fell today. Symbols are in parentheses.
D. Medical Industries Ltd. (DMED IT) climbed the most in a month, gaining 5.1 percent to 12.22 shekels. The developer of drug-delivery devices said a unit received U.S. Food and Drug Administration approval to sell its Spring Universal Infusion sets in the U.S.
Teva Pharmaceutical Industries Ltd. (TEVA) fell to the lowest since November 2008, decreasing 0.9 percent to 155.70 shekels. The European Commission said it will examine whether a 2005 agreement between the world’s largest maker of generic drugs and Cephalon Inc. to settle British and U.S. patent litigation “may have the object or effect of hindering the entry” of the sleep-disorder drug modafinil.
To contact the reporter on this story: Ronit Goodman in Tel Aviv at rgoodman9@bloomberg.net
To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net
Rate this Page